Recent Finacing
Recent Raise
ReproNovo is a biopharmaceutical company developing reproductive-medicine and women’s-health therapies, advancing Phase 2-ready leflutrozole (male infertility) and nolasiban (adenomyosis/embryo implantation), based in Lausanne with development in Copenhagen and Barcelona.
